Shanghai Jiaoda Onlly Co Ltd Market Cap ($455.85 Million)
Market Cap & Net Worth: Shanghai Jiaoda Onlly Co Ltd (600530)
Shanghai Jiaoda Onlly Co Ltd market cap. Shanghai Jiaoda Onlly Co Ltd (SHG:600530) has a market capitalization of $455.85 Million (CN¥3.12 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #12378 globally and #3604 in its home market, demonstrating a 10.74% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Jiaoda Onlly Co Ltd's stock price CN¥4.02 by its total outstanding shares 774920000 (774.92 Million). Also see 600530 cash flow metrics for how efficiently the company converts equity into cash flow.
Shanghai Jiaoda Onlly Co Ltd Market Cap History (2016–2026)
Shanghai Jiaoda Onlly Co Ltd market cap history from 2016 to 2026. Data shows change from $831.38 Million to $455.85 Million (-7.33% CAGR). Check 600530 stock price and chart for real-time trading data and today's change.
Shanghai Jiaoda Onlly Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Jiaoda Onlly Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 600530 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.68x
Shanghai Jiaoda Onlly Co Ltd's market cap is 1.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.97x
Shanghai Jiaoda Onlly Co Ltd's market cap is 17.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $831.38 Million | $268.79 Million | $137.20 Million | 3.09x | 6.06x |
| 2017 | $825.69 Million | $282.07 Million | $160.43 Million | 2.93x | 5.15x |
| 2018 | $501.21 Million | $260.06 Million | -$506.04 Million | 1.93x | N/A |
| 2019 | $557.90 Million | $342.16 Million | -$70.82 Million | 1.63x | N/A |
| 2020 | $320.91 Million | $332.70 Million | $89.53 Million | 0.96x | 3.58x |
| 2021 | $500.07 Million | $362.58 Million | $37.18 Million | 1.38x | 13.45x |
| 2022 | $430.90 Million | $377.15 Million | -$498.42 Million | 1.14x | N/A |
| 2023 | $305.03 Million | $296.33 Million | -$35.08 Million | 1.03x | N/A |
| 2024 | $547.70 Million | $325.18 Million | $30.48 Million | 1.68x | 17.97x |
Competitor Companies of 600530 by Market Capitalization
Companies near Shanghai Jiaoda Onlly Co Ltd in the global market cap rankings as of November 8, 2026. Also see Shanghai Jiaoda Onlly Co Ltd asset portfolio for a full breakdown of the balance sheet.
Key companies related to Shanghai Jiaoda Onlly Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Shanghai Jiaoda Onlly Co Ltd (2016–2026)
Market capitalization of Shanghai Jiaoda Onlly Co Ltd from 2016 to today. Between 2016 and today, Shanghai Jiaoda Onlly Co Ltd's market cap moved from $831.38 Million to $ 455.85 Million, with a yearly change of -7.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥455.85 Million | -37.58% |
| 2025 | CN¥730.26 Million | +33.33% |
| 2024 | CN¥547.70 Million | +79.55% |
| 2023 | CN¥305.03 Million | -29.21% |
| 2022 | CN¥430.90 Million | -13.83% |
| 2021 | CN¥500.07 Million | +55.83% |
| 2020 | CN¥320.91 Million | -42.48% |
| 2019 | CN¥557.90 Million | +11.31% |
| 2018 | CN¥501.21 Million | -39.30% |
| 2017 | CN¥825.69 Million | -0.68% |
| 2016 | CN¥831.38 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Shanghai Jiaoda Onlly Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $455.85 Million USD |
| MoneyControl | $455.85 Million USD |
| MarketWatch | $455.85 Million USD |
| marketcap.company | $455.85 Million USD |
| Reuters | $455.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai Jiaoda Onlly Co Ltd
Shanghai Jiaoda Onlly Co.,Ltd, together with its subsidiaries, engages in the research, development, and production of raw materials and end products of food and health food in China. It is also involved in the operation and management of elderly medical care institutions, including hospitals and nursing homes; and the provision of management consulting services to non-profit hospitals, nursing h… Read more